Pharmapedia

14 May 2026

Experts Raise Concerns Over UK’s Fast-Track Drug Approval System

A newly introduced drug approval pathway in the United Kingdom is facing criticism from healthcare experts, who argue that the system may favor pharmaceutical companies more than patients or the public healthcare system. According to an analysis published in The BMJ, the accelerated process could lead to quicker market access for medicines without guaranteeing meaningful benefits for patients.

28 April 2026

New Era in Deafness Treatment : FDA Clears First Gene Therapy to Restore Hearing

In a landmark medical breakthrough, the U.S. Food and Drug Administration has approved the world’s first gene therapy designed to treat a rare form of inherited hearing loss, marking a major step toward curing, not just managing, deafness.

24 March 2026

Takeda's Dengue Vaccine Clears India's Expert Panel, Approval Imminent

India has moved a decisive step closer to having its first tetravalent dengue vaccine on the market after a Subject Expert Committee (SEC) under the Drugs Controller General of India (DCGI) recommended approving Takeda Biopharmaceuticals' Dengue Tetravalent Vaccine (TDV) for import and use in individuals aged 4 to 60 years.

21 January 2026

India’s Homegrown Antibiotic Moves Closer to Europe as Wockhardt Files EMA Application

Wockhardt has taken a major step in global healthcare by filing a Marketing Authorisation Application with the European Medicines Agency, EMA for its new antibiotic WCK 5222

20 January 2026

Mounjaro : A strong performer in the last 9 months

Mounjaro (tirzepatide) has emerged as one of the most impactful brands in the GLP‑1 category, showing remarkable traction over the last nine months. With growing acceptance among clinicians and increasing awareness among patients, Mounjaro’s performance reflects both strong clinical confidence and rising demand in the metabolic therapy space.

1 January 2026

Peptides in Cosmetics

Vinay Kumar Singh.
Head-Formulation
Kumar Organic Products Research Centre Pvt. Ltd.,
Bengaluru
Email : formulation_krc@kopresearchcentre.net

26 December 2025

New Research finds ADHD Stimulant medications work in unexpected way

Researchers at Washington University School of Medicine in St. Louis suggest that common stimulant medications used to treat attention-deficit/hyperactivity disorder (ADHD), such as Ritalin and Adderall, may work in ways scientists didn’t previously understand. The findings challenge the long-held belief that these drugs primarily improve attention by acting directly on the brain’s attention circuits.

19 December 2025

Regulatory Harmonization and India’s Global Pharma Credibility

In global pharmaceuticals, credibility is no longer conferred by capacity alone. It is earned— slowly, visibly, and irreversibly—through regulatory trust. As drug supply chains fragment, re- regionalize, and digitize, the decisive question for India’s pharmaceutical future is no longer how much we manufacture, but how seamlessly our regulatory systems align with the world we serve.

18 December 2025

Clues to Alzheimer’s disease may be hiding in our ‘junk’ DNA

When most of us think of DNA, we have a vague idea it’s made up of genes that give us our physical features, our behavioural quirks, and keep our cells and organs running.